| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyCellularComponent | site of DNA damage | 7.44e-05 | 137 | 270 | 9 | GO:0090734 | |
| GeneOntologyCellularComponent | apical junction complex | 2.20e-04 | 158 | 270 | 9 | GO:0043296 | |
| GeneOntologyCellularComponent | bicellular tight junction | 3.07e-04 | 131 | 270 | 8 | GO:0005923 | |
| GeneOntologyCellularComponent | site of double-strand break | 3.40e-04 | 101 | 270 | 7 | GO:0035861 | |
| GeneOntologyCellularComponent | tight junction | 4.58e-04 | 139 | 270 | 8 | GO:0070160 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | RAPGEF6 EPPK1 KMT2B MYO10 CYTH3 EXOSC8 TSC2 ANKHD1 BIRC6 CASZ1 TYK2 RAB43 SEC16A NAV2 POLL PLEC LMTK2 CEP192 LRRK1 FBXO46 SLC2A1 IFNLR1 KCNH3 ARHGEF40 AATK LATS2 KLF10 ZNF592 SBF2 PCNX1 ZFYVE26 LTBP3 CABIN1 ESPL1 SPEN SOWAHB SYMPK | 1.74e-13 | 1105 | 276 | 37 | 35748872 |
| Pubmed | Docking motif-guided mapping of the interactome of protein phosphatase-1. | RBM26 TSC2 ELFN2 TMEM132C TRIM42 CAMSAP3 CEP192 PREX2 RIMBP2 PPP1R36 | 8.50e-10 | 80 | 276 | 10 | 19389623 |
| Pubmed | PDXDC1 CDCA3 EPS15 GPRIN1 BIRC6 BBX AMOTL1 ARL13B SEC16A ABCD3 SPTY2D1 NOL8 ANK3 CAMK4 GPATCH1 APBB2 ARFGEF1 GPRIN3 CEP192 ARHGAP1 PPP2R3A TENM3 TJP1 EXD2 CTBP1 SPEN | 8.82e-10 | 777 | 276 | 26 | 35844135 | |
| Pubmed | CDCA3 GOLM2 CCDC18 GPRIN1 BIRC6 PTPN2 ARL13B DHPS SEC16A ABCD3 PINX1 MPP7 RELCH ANK3 PPM1E CAMSAP3 LMTK2 GPRIN3 CEP192 IWS1 PPP1R3D ARHGAP1 GRPEL1 PPP2R3A MED4 TJP1 SBF2 SSH2 CDC25A SYMPK | 1.69e-09 | 1049 | 276 | 30 | 27880917 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | RAPGEF6 MAP2 CCDC18 TSC2 FAM117A PRRC2C SRGAP1 SEC16A NAV2 MAP3K9 PLEC NTRK3 NCKIPSD CAMSAP3 LMTK2 CEP192 VIRMA DENND4C IVNS1ABP RESF1 SLF2 TJP1 SSH2 KIF13A PALLD AQR | 7.35e-09 | 861 | 276 | 26 | 36931259 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | RAD18 RAPGEF6 KMT2B TATDN2 GPATCH8 GPRIN1 EMSY HNRNPH1 SCML2 SEC16A PLEC CAMSAP3 VIRMA PALB2 IWS1 ZNF592 TKT MDC1 TRAPPC10 UNK EIF3B ESPL1 SPEN SYMPK | 1.74e-08 | 774 | 276 | 24 | 15302935 |
| Pubmed | Mouse screen reveals multiple new genes underlying mouse and human hearing loss. | EPS15 RAD18 MYO10 GOLM2 BIVM CCDC18 UBAP1 DAP ADAR PTHLH PTPN2 BBX AMOTL1 COQ9 DHPS FHIP1A TCTE1 MCPH1 CAMSAP3 CC2D1B CPT2 VIRMA DENND4C IFNLR1 GPBP1L1 TRAPPC10 UNK RIMBP2 MYO15A ZNF287 SYMPK | 2.11e-08 | 1242 | 276 | 31 | 30973865 |
| Pubmed | EPS15 METTL3 KMT2B RBM26 EXOSC8 GPATCH8 ANKHD1 CASZ1 EMSY SCML2 BBX ABCD3 FHIP1A SPTY2D1 MPP7 NOL8 CAMSAP3 TOPBP1 VIRMA SLC2A1 IWS1 CCNT1 MED4 GPBP1L1 ZNF592 EXD2 MDC1 UNK CTBP1 EIF3B SPEN DDX28 AQR | 1.32e-07 | 1497 | 276 | 33 | 31527615 | |
| Pubmed | RAPGEF6 KMT2B RBM26 GPRIN1 ANKHD1 ADAR EMSY SCML2 PRRC2C AMOTL1 SEC16A RPRD2 ANK3 TJP1 MDC1 SPEN PALLD SYMPK | 5.04e-07 | 549 | 276 | 18 | 38280479 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | RAD18 KMT2B PRPF6 GPATCH8 ADAR CASZ1 EMSY HNRNPH1 HNRNPH2 SCML2 HOXC9 BBX RPRD2 SPTY2D1 NOL8 C14orf93 MCPH1 GPATCH1 TOPBP1 PALB2 THOC5 IWS1 ARNT MED4 SLF2 MDC1 CABIN1 SPEN SYMPK | 5.77e-07 | 1294 | 276 | 29 | 30804502 |
| Pubmed | KLF12 RAD18 RAPGEF6 GPATCH8 ANKHD1 ADCY3 C5orf34 SCML2 KCNH1 SEC16A MAP3K9 PLEC CPLANE1 SPTY2D1 ANK3 LMTK2 CEP192 CPT2 SLC2A1 ZNF750 RESF1 SBF2 PRKAA1 TRAPPC10 KIF13A ESPL1 | 6.58e-07 | 1084 | 276 | 26 | 11544199 | |
| Pubmed | Mammalian APE1 controls miRNA processing and its interactome is linked to cancer RNA metabolism. | CDCA3 RAPGEF6 GOLM2 CYTH3 CYTH2 HIC2 TSC2 ANKHD1 ADAR ADCY3 EMSY HNRNPH1 RAB43 PINX1 USP28 ST3GAL4 SNX14 EXD2 TRAPPC10 LTBP3 EIF3B KIF13A RUBCN | 1.64e-06 | 925 | 276 | 23 | 28986522 |
| Pubmed | Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing. | RBM26 ADAR HNRNPH1 HNRNPH2 SCML2 RPRD2 PLEC NOL8 SLC2A1 CCNT1 MDC1 AQR | 2.04e-06 | 271 | 276 | 12 | 32433965 |
| Pubmed | EPS15 METTL3 RAD18 RBM26 ADAR SEC16A NAV2 RPRD2 CAMSAP3 TOPBP1 DENND4C IWS1 KLF10 KIF13A SPEN PALLD | 3.23e-06 | 503 | 276 | 16 | 16964243 | |
| Pubmed | RAD18 EXOSC8 EMSY RPRD2 MCPH1 HUS1 USP28 TOPBP1 SHLD1 SLC2A1 PALB2 MED4 SLF2 MDC1 CABIN1 | 4.05e-06 | 453 | 276 | 15 | 29656893 | |
| Pubmed | RBM26 GPATCH8 HNRNPH1 HNRNPH2 PRRC2C ZPR1 UCHL3 SEC16A RPRD2 RANBP9 TKT MDC1 CTBP1 PALLD | 4.41e-06 | 399 | 276 | 14 | 35987950 | |
| Pubmed | METTL3 CCDC18 EXOSC8 BBX SEC16A PINX1 NPEPPS RANBP9 TOPBP1 CEP43 PALB2 DENND4C IWS1 MED4 ZNF592 CTBP1 CABIN1 SPEN | 4.86e-06 | 645 | 276 | 18 | 25281560 | |
| Pubmed | INTU MYO10 GPATCH8 ADCY3 PRRC2C SEC16A PPM1E CEP192 VIRMA TENM3 RIMBP2 SPEN RUBCN AQR | 5.53e-06 | 407 | 276 | 14 | 12693553 | |
| Pubmed | HIC2 ANKHD1 NAV2 RPRD2 RELCH USP28 TOPBP1 LMTK2 LRRK1 ERI2 IVNS1ABP ZNF592 MDC1 UNK PCNX1 ESPL1 | 6.09e-06 | 529 | 276 | 16 | 14621295 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | EPS15 RAPGEF6 RBM26 GPRIN1 ANKHD1 ADAR EMSY HNRNPH1 SCML2 PRRC2C SEC16A ABCD3 RPRD2 NOL8 NRBF2 USP28 CAMK4 GPATCH1 CCNT1 TJP1 TKT PALLD | 6.56e-06 | 934 | 276 | 22 | 33916271 |
| Pubmed | METTL3 RAD18 RBM26 PRPF6 GPATCH8 ADAR PTPN2 UCHL3 PLEC USP28 VIRMA THOC5 IWS1 CCNT1 MED4 ZNF592 TKT MDC1 EIF3B MYO15A IRX2 AQR SYMPK | 7.41e-06 | 1014 | 276 | 23 | 32416067 | |
| Pubmed | EPS15 RAPGEF6 KMT2B ANKHD1 BIRC6 SEC16A ABCD3 PLEC CAMSAP3 PALB2 DENND4C RESF1 ZNF592 CTBP1 | 7.48e-06 | 418 | 276 | 14 | 34709266 | |
| Pubmed | 8.27e-06 | 60 | 276 | 6 | 34761192 | ||
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | RAD18 KMT2B EXOSC8 GPATCH8 CASZ1 EMSY SCML2 BBX ZNF483 PINX1 TOPBP1 IWS1 CCNT1 ZNF592 MDC1 CABIN1 SPEN | 8.72e-06 | 608 | 276 | 17 | 36089195 |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | EPS15 KLF12 RAPGEF6 EPPK1 APOBR TMEM132C PLEC FHIP1A ANK3 AATK ANKRA2 MDC1 UNK SPEN | 1.03e-05 | 430 | 276 | 14 | 35044719 |
| Pubmed | EPS15 CYTH3 CYTH2 TSC2 EMSY PRRC2C SEC16A PPP1R3F CACNA1A ANK3 USP28 NPEPPS CAMSAP3 RANBP9 SIPA1 VIRMA TJP1 CTBP1 RIMBP2 EML1 SSH2 CABIN1 | 1.05e-05 | 963 | 276 | 22 | 28671696 | |
| Pubmed | A novel p53 regulator, C16ORF72/TAPR1, buffers against telomerase inhibition. | BIRC6 EMSY BBX MAP3K15 CPLANE1 SPTY2D1 MARCHF8 PALB2 SGK2 GRPEL1 PPP2R3A ARNT MED4 TKT | 1.06e-05 | 431 | 276 | 14 | 33660365 |
| Pubmed | 1.26e-05 | 222 | 276 | 10 | 37071664 | ||
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | PRPF6 GPATCH8 ADAR HNRNPH1 HNRNPH2 SEC16A ABCD3 RPRD2 GPATCH1 LMTK2 ZNF592 MDC1 ESPL1 AQR | 1.33e-05 | 440 | 276 | 14 | 34244565 |
| Pubmed | EPPK1 MYO10 ADAR PRRC2C AMOTL1 SEC16A PLEC SLC29A4 COL5A2 ARHGAP1 LIF EIF3B | 1.59e-05 | 332 | 276 | 12 | 37433992 | |
| Pubmed | 1.69e-05 | 7 | 276 | 3 | 31704785 | ||
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | RBM26 ADAR EMSY SCML2 BBX RPRD2 NOL8 GPATCH1 CCNT1 MDC1 SPEN | 1.85e-05 | 283 | 276 | 11 | 30585729 |
| Pubmed | Placentation defects are highly prevalent in embryonic lethal mouse mutants. | 1.90e-05 | 103 | 276 | 7 | 29539633 | |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | MYO10 PRPF6 PTPN2 SCML2 UCHL3 AMOTL1 ABCD3 PLEC MPP7 USP50 USP28 NPEPPS RANBP9 CEP192 IWS1 IVNS1ABP LAT TJP1 RIMBP2 EIF3B CDC25A AQR | 2.02e-05 | 1005 | 276 | 22 | 19615732 |
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | RBM26 TSC2 PRPF6 EMSY SCML2 GPATCH1 ARFGEF1 CCNT1 MDC1 SPEN AQR SYMPK | 2.07e-05 | 341 | 276 | 12 | 32971831 |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | INTU TSC2 PRPF6 FAM117A BBX AMOTL1 DHPS SEC16A ABCD3 SDF2L1 POLL PLEC CEP97 RPGRIP1 RELCH ANK3 RBL1 CAMSAP3 RANBP9 CEP43 DENND4C IVNS1ABP MED4 GPBP1L1 TRAPPC10 CTBP1 | 2.22e-05 | 1321 | 276 | 26 | 27173435 |
| Pubmed | FRMD4A regulates epithelial polarity by connecting Arf6 activation with the PAR complex. | 2.69e-05 | 8 | 276 | 3 | 20080746 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | RAD18 RBM26 PRPF6 ADAR EMSY HNRNPH1 SCML2 BBX PRRC2C SEC16A PINX1 RPRD2 NOL8 GPATCH1 TOPBP1 CCNT1 SLF2 TJP1 MDC1 SPEN SYMPK | 2.89e-05 | 954 | 276 | 21 | 36373674 |
| Pubmed | Charting the landscape of tandem BRCT domain-mediated protein interactions. | RAD18 TATDN2 EXOSC8 HIC2 ABCD3 USH2A DNHD1 RPGRIP1 NPEPPS RANBP9 CEP43 THOC5 CCNT1 MDC1 CTBP1 EIF3B PALLD | 3.00e-05 | 670 | 276 | 17 | 22990118 |
| Pubmed | 3.11e-05 | 152 | 276 | 8 | 34299191 | ||
| Pubmed | KLF12 RAD18 KMT2B HIC2 GPATCH8 ANKHD1 EMSY HOXC9 BBX PRRC2C SEC16A ABCD3 RPRD2 CEP192 GRPEL1 ARNT MED4 RESF1 KLF10 ZNF592 MDC1 UNK CTBP1 EIF3B CABIN1 SPEN SYMPK | 3.12e-05 | 1429 | 276 | 27 | 35140242 | |
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | EPS15 RAD18 RAPGEF6 MYO10 RBM26 UBAP1 C5orf34 SEC16A RPRD2 CEP97 NCKIPSD CEP43 DENND4C IWS1 PPP1R3D ARHGAP1 GPBP1L1 TJP1 SBF2 GSTCD SSH2 ESPL1 | 3.29e-05 | 1038 | 276 | 22 | 26673895 |
| Pubmed | Comparative interactome analysis of α-arrestin families in human and Drosophila. | PDXDC1 TSC2 GPATCH8 ABCD3 GPATCH1 RANBP9 LMTK2 SLC2A1 CCNT1 SPEN DDX28 | 4.63e-05 | 313 | 276 | 11 | 38270169 |
| Pubmed | EPS15 EPPK1 PRPF6 ADAR SRGAP1 UCHL3 SEC16A ABCD3 PINX1 SDF2L1 PLEC RBL1 CAMSAP3 RANBP9 VIRMA PREX2 THOC5 ARHGAP1 CCNT1 ARHGEF40 | 5.02e-05 | 916 | 276 | 20 | 32203420 | |
| Pubmed | Spatial centrosome proteome of human neural cells uncovers disease-relevant heterogeneity. | 5.90e-05 | 27 | 276 | 4 | 35709258 | |
| Pubmed | EPS15 ATP6V0B MAP2 ADCY3 SVEP1 HNRNPH1 RPRD2 USP28 ARHGAP1 TENM3 ESPL1 | 5.97e-05 | 322 | 276 | 11 | 26514267 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | EPS15 INTU MAP2 GOLM2 DAP ADCY3 CASZ1 TYK2 RPRD2 CENATAC ANK3 MCPH1 NPEPPS CAMSAP3 APBB2 CEP192 CEP43 DNAH1 SGK2 SHISA9 PPP2R2C PPP2R3A LATS2 TJP1 SBF2 CTBP1 GLIS1 | 6.26e-05 | 1489 | 276 | 27 | 28611215 |
| Pubmed | Six transcripts map within 200 kilobases of the myotonic dystrophy expanded repeat. | 6.28e-05 | 2 | 276 | 2 | 9585442 | |
| Pubmed | 6.28e-05 | 2 | 276 | 2 | 30007356 | ||
| Pubmed | 6.28e-05 | 2 | 276 | 2 | 38807600 | ||
| Pubmed | 6.28e-05 | 2 | 276 | 2 | 33509238 | ||
| Pubmed | Differential regulation of centrosome integrity by DNA damage response proteins. | 6.28e-05 | 2 | 276 | 2 | 18635967 | |
| Pubmed | Structural insights into recognition of MDC1 by TopBP1 in DNA replication checkpoint control. | 6.28e-05 | 2 | 276 | 2 | 23891287 | |
| Pubmed | The LKB1 tumor suppressor negatively regulates mTOR signaling. | 6.28e-05 | 2 | 276 | 2 | 15261145 | |
| Pubmed | Characterization of LILRB3 and LILRA6 allelic variants in the Japanese population. | 6.28e-05 | 2 | 276 | 2 | 33526815 | |
| Pubmed | 6.28e-05 | 2 | 276 | 2 | 31752345 | ||
| Pubmed | Slitrk1-deficient mice display elevated anxiety-like behavior and noradrenergic abnormalities. | 6.28e-05 | 2 | 276 | 2 | 18794888 | |
| Pubmed | 6.28e-05 | 2 | 276 | 2 | 28362255 | ||
| Pubmed | 6.28e-05 | 2 | 276 | 2 | 28386021 | ||
| Pubmed | 6.28e-05 | 2 | 276 | 2 | 11373277 | ||
| Pubmed | 6.28e-05 | 2 | 276 | 2 | 38928066 | ||
| Pubmed | 6.28e-05 | 2 | 276 | 2 | 31601460 | ||
| Pubmed | 6.28e-05 | 2 | 276 | 2 | 23908141 | ||
| Pubmed | Diversity of the human LILRB3/A6 locus encoding a myeloid inhibitory and activating receptor pair. | 6.28e-05 | 2 | 276 | 2 | 24096970 | |
| Pubmed | Postnatal Dynamic Ciliary ARL13B and ADCY3 Localization in the Mouse Brain. | 6.28e-05 | 2 | 276 | 2 | 38334651 | |
| Pubmed | 6.28e-05 | 2 | 276 | 2 | 17499243 | ||
| Pubmed | FMIP, a novel Fms-interacting protein, affects granulocyte/macrophage differentiation. | 6.28e-05 | 2 | 276 | 2 | 10597251 | |
| Pubmed | 6.28e-05 | 2 | 276 | 2 | 16705167 | ||
| Pubmed | 6.28e-05 | 2 | 276 | 2 | 39084258 | ||
| Pubmed | 6.28e-05 | 2 | 276 | 2 | 37189200 | ||
| Pubmed | Distinct frequency patterns of LILRB3 and LILRA6 allelic variants in Europeans. | 6.28e-05 | 2 | 276 | 2 | 36449053 | |
| Pubmed | Involvement of BREK, a serine/threonine kinase enriched in brain, in NGF signalling. | 6.28e-05 | 2 | 276 | 2 | 15005709 | |
| Pubmed | 6.28e-05 | 2 | 276 | 2 | 36077054 | ||
| Pubmed | 6.28e-05 | 2 | 276 | 2 | 25511211 | ||
| Pubmed | Noncanonical K27-linked polyubiquitination of TIEG1 regulates Foxp3 expression and tumor growth. | 6.28e-05 | 2 | 276 | 2 | 21471442 | |
| Pubmed | 6.28e-05 | 2 | 276 | 2 | 19617579 | ||
| Pubmed | 6.28e-05 | 2 | 276 | 2 | 33217448 | ||
| Pubmed | 6.28e-05 | 2 | 276 | 2 | 12566417 | ||
| Pubmed | 6.28e-05 | 2 | 276 | 2 | 37740860 | ||
| Pubmed | 6.28e-05 | 2 | 276 | 2 | 19055622 | ||
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | RBM26 HIC2 ANKHD1 ADAR CASZ1 EMSY BBX PRRC2C DHFR FOXN1 RBL1 USP28 RUNX1T1 ARNT RNASEL CDC25A CABIN1 SPEN SYMPK | 6.34e-05 | 857 | 276 | 19 | 25609649 |
| Pubmed | 6.60e-05 | 125 | 276 | 7 | 29467281 | ||
| Pubmed | RAPGEF6 TSC2 BIRC6 AMOTL1 SEC16A MPP7 NCKIPSD CEP192 DENND4C LATS2 TJP1 TRAPPC10 UNK | 6.61e-05 | 446 | 276 | 13 | 24255178 | |
| Pubmed | PRPF6 ADAR HNRNPH1 HNRNPH2 PLEC KIAA2012 CAMSAP3 RANBP9 EIF3B PALLD | 7.05e-05 | 272 | 276 | 10 | 31010829 | |
| Pubmed | RAPGEF6 ANKHD1 TYK2 PRRC2C ABCD3 RBL1 CAMSAP3 CC2D1B TGFBI GRPEL1 ARHGEF40 ARNT PRKAA1 PALLD RUBCN AQR | 7.31e-05 | 650 | 276 | 16 | 38777146 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | METTL3 EPPK1 EXOSC8 PRPF6 ADAR HNRNPH1 HNRNPH2 PTPN2 PRRC2C SRGAP1 AMOTL1 ABCD3 PLEC NOL8 VIRMA SLC2A1 THOC5 ARHGAP1 TJP1 TKT MDC1 EIF3B SPEN AQR | 7.43e-05 | 1257 | 276 | 24 | 36526897 |
| Pubmed | 7.78e-05 | 11 | 276 | 3 | 28059666 | ||
| Pubmed | DBIRD complex integrates alternative mRNA splicing with RNA polymerase II transcript elongation. | 7.92e-05 | 89 | 276 | 6 | 22446626 | |
| Pubmed | KSHV episome tethering sites on host chromosomes and regulation of latency-lytic switch by CHD4. | 8.45e-05 | 130 | 276 | 7 | 35545047 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | KMT2B HIC2 TSC2 GPRIN1 BIRC6 HNRNPH1 SAMD9L ADAMTS9 MYO3B ABCD3 MAP3K9 MCPH1 CAMSAP3 ST3GAL4 IVNS1ABP ZNF592 SYMPK | 9.46e-05 | 736 | 276 | 17 | 29676528 |
| Pubmed | 1.03e-04 | 31 | 276 | 4 | 19690177 | ||
| Pubmed | 1.03e-04 | 12 | 276 | 3 | 32807950 | ||
| Pubmed | 1.03e-04 | 12 | 276 | 3 | 21436046 | ||
| Pubmed | 1.15e-04 | 234 | 276 | 9 | 36243803 | ||
| Pubmed | RBM26 PRPF6 ANKHD1 ADAR HNRNPH1 HNRNPH2 PINX1 NOL8 GPATCH1 EIF3B SPEN | 1.16e-04 | 347 | 276 | 11 | 16033648 | |
| Pubmed | PDXDC1 CDCA3 ADAR HNRNPH1 SCML2 SEC16A ABCD3 RPRD2 CEP97 USP28 RANBP9 CEP43 ARHGAP1 | 1.16e-04 | 472 | 276 | 13 | 38943005 | |
| Pubmed | 1.33e-04 | 13 | 276 | 3 | 21659603 | ||
| Pubmed | The Rb/E2F pathway modulates neurogenesis through direct regulation of the Dlx1/Dlx2 bigene cluster. | 1.33e-04 | 13 | 276 | 3 | 22699903 | |
| Pubmed | USP9X Deubiquitylates DVL2 to Regulate WNT Pathway Specification. | 1.36e-04 | 62 | 276 | 5 | 31340145 | |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | EPS15 EPPK1 RBM26 EXOSC8 PRPF6 ANKHD1 ADAR HNRNPH1 PRRC2C AMOTL1 SEC16A SDF2L1 PLEC ANK3 NPEPPS CAMSAP3 RANBP9 CPT2 IVNS1ABP TKT EIF3B SYMPK | 1.43e-04 | 1149 | 276 | 22 | 35446349 |
| Interaction | YWHAH interactions | RAPGEF6 EPPK1 MAP2 CYTH2 CCDC18 TSC2 PRPF6 FAM117A PRRC2C SRGAP1 SEC16A NAV2 MAP3K9 MAP3K15 PLEC NCKIPSD CAMSAP3 LMTK2 CEP192 SIPA1 VIRMA DENND4C IVNS1ABP PPP1R3D GRPEL1 GPBP1L1 LATS2 RESF1 SLF2 TJP1 PRKAA1 TRAPPC10 SSH2 CDC25A PALLD RUBCN AQR | 1.85e-07 | 1102 | 267 | 37 | int:YWHAH |
| Interaction | TOP3B interactions | RAPGEF6 EPPK1 KMT2B MYO10 CYTH3 EXOSC8 TSC2 ANKHD1 BIRC6 CASZ1 TYK2 RAB43 SEC16A NAV2 POLL PLEC VEPH1 LMTK2 CEP192 LRRK1 FBXO46 SLC2A1 IFNLR1 KCNH3 ARHGEF40 AATK LATS2 KLF10 ZNF592 SBF2 MDC1 UNK PCNX1 ZFYVE26 LTBP3 CABIN1 ESPL1 SPEN SOWAHB DDX28 SYMPK | 4.60e-06 | 1470 | 267 | 41 | int:TOP3B |
| Interaction | SFN interactions | RAPGEF6 MAP2 CYTH2 CCDC18 TSC2 PTPN2 PRRC2C DHFR NAV2 PLEC NTRK3 CAMSAP3 LMTK2 CEP192 VIRMA DENND4C PPP1R3D ARNT TJP1 TKT PRKAA1 SSH2 CDC25A KIF13A PALLD | 6.03e-06 | 692 | 267 | 25 | int:SFN |
| Interaction | BRCA1 interactions | RAD18 TATDN2 EXOSC8 PRPF6 EMSY HNRNPH1 HNRNPH2 DHPS SEC16A PLEC USH2A DNHD1 RPGRIP1 MCPH1 HUS1 RBL1 USP28 NPEPPS RANBP9 TOPBP1 ARFGEF1 LRRK1 RUNX1T1 CEP43 PALB2 IFNLR1 GRPEL1 ARNT SLF2 TKT EXD2 MDC1 CTBP1 EIF3B CABIN1 PALLD | 9.26e-06 | 1249 | 267 | 36 | int:BRCA1 |
| Interaction | CNOT9 interactions | RAD18 ANKHD1 BIRC6 HNRNPH1 PRRC2C SEC16A RPRD2 CEP97 NRBF2 CEP192 AATK GPBP1L1 UNK | 1.35e-05 | 231 | 267 | 13 | int:CNOT9 |
| Cytoband | 19q13.4 | 1.19e-04 | 79 | 276 | 5 | 19q13.4 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | RBM26 TSC2 ELFN2 TMEM132C PPP1R3F TRIM42 CAMSAP3 LMTK2 CEP192 PREX2 PPP1R3D AATK RIMBP2 PPP1R36 | 2.97e-09 | 181 | 177 | 14 | 694 |
| GeneFamily | Receptor Tyrosine Kinases|CD molecules | 6.16e-04 | 40 | 177 | 4 | 321 | |
| GeneFamily | CD molecules|Inhibitory leukocyte immunoglobulin like receptors | 9.35e-04 | 5 | 177 | 2 | 1182 | |
| GeneFamily | G-patch domain containing|Minor histocompatibility antigens | 1.24e-03 | 22 | 177 | 3 | 579 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | RELN RAPGEF6 SYN3 MAP2 BIVM RBM26 TATDN2 ANO5 TSC2 SLITRK1 CASZ1 FAT2 SRGAP1 MAP3K9 CACNA1A COL11A1 ANK3 NTRK3 ARFGEF1 GPRIN3 RUNX1T1 SGK2 PPP2R2C PPP2R3A AATK SBF2 RIMBP2 SSH2 KIF13A IRX2 CSGALNACT1 | 6.10e-07 | 1106 | 273 | 31 | M39071 |
| Coexpression | GSE21670_UNTREATED_VS_TGFB_IL6_TREATED_CD4_TCELL_UP | CDCA3 CYTH2 CCDC18 CASZ1 NCKIPSD TOPBP1 CEP192 ERI2 PCNX1 CDC25A PALLD | 6.55e-06 | 194 | 273 | 11 | M7467 |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | BNC2 SYN3 MYO10 SVEP1 TMEM132C SRGAP1 NAV2 TBX5 COL5A2 ADAMTS8 RUNX1T1 PREX2 PALLD MCOLN3 | 1.85e-11 | 193 | 274 | 14 | 99525545552b371c86b18b6ea6f4897dc6e9a9ec |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | BNC2 MYO10 ABCA10 SVEP1 LURAP1L SRGAP1 NAV2 TBX5 COL5A2 APBB2 ADAMTS8 RUNX1T1 TENM3 PALLD | 2.12e-11 | 195 | 274 | 14 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | BNC2 SYN3 MYO10 ABCA10 SVEP1 LURAP1L TMEM132C SRGAP1 COL5A2 RUNX1T1 PREX2 PALLD MCOLN3 | 1.11e-10 | 181 | 274 | 13 | 9ede19228ba5c0668a9c06c915510b95585216ef |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | BNC2 SYN3 MYO10 ABCA10 SVEP1 SRGAP1 NAV2 TBX5 COL5A2 ADAMTS8 RUNX1T1 TENM3 PALLD | 3.83e-10 | 200 | 274 | 13 | e8462395fee0a532d1e7ec7f1795f28c42af6541 |
| ToppCell | LPS_only-Stromal_mesenchymal|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | BNC2 SVEP1 LURAP1L TMEM132C SRGAP1 TBX5 COL5A2 ADAMTS8 RUNX1T1 THBS2 TENM3 PALLD | 2.86e-09 | 192 | 274 | 12 | 162d8b5858d150ecbbd1c9bf2b19c6c9cd50a158 |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | MAP2 CYTH3 ADCY3 SVEP1 SRGAP1 NAV2 COL5A2 NTRK3 RUNX1T1 PREX2 TENM3 PALLD | 3.82e-09 | 197 | 274 | 12 | 9b480f9c799a244bfee64487abd8a1bf07c9a3a2 |
| ToppCell | Tracheal-NucSeq-Stromal-Peri/Epineurial_|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | BNC2 KLF12 ELFN2 ABCA10 ADCY3 SVEP1 TMEM132C COL5A2 MRAS RUNX1T1 SLC2A1 TH | 4.28e-09 | 199 | 274 | 12 | 3835452e4848d7f7dd8651c17b746b271ef39688 |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | BNC2 ABCA10 SVEP1 TMEM132C MYO3B NAV2 TBX5 COL5A2 NTRK3 RUNX1T1 PREX2 THBS2 | 4.53e-09 | 200 | 274 | 12 | 58b38f9a484ee94191091a0659ed62ebed2d4a14 |
| ToppCell | Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | BNC2 SRGAP1 NAV2 C3AR1 LILRB5 LRRK1 CRHBP CSF1R SIGLEC1 FYB1 CSGALNACT1 | 2.21e-08 | 185 | 274 | 11 | 8207f9eff113eed429e961748c6b17d672a13b33 |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | BNC2 SYN3 ABCA10 SVEP1 NAV2 TBX5 COL5A2 ADAMTS8 RUNX1T1 TENM3 PALLD | 3.07e-08 | 191 | 274 | 11 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | BNC2 SYN3 ABCA10 SVEP1 NAV2 TBX5 COL5A2 ADAMTS8 RUNX1T1 TENM3 PALLD | 3.23e-08 | 192 | 274 | 11 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D231|Adult / Lineage, Cell type, age group and donor | BNC2 SYN3 SVEP1 SRGAP1 TBX5 COL5A2 ADAMTS8 RUNX1T1 THBS2 TENM3 MCOLN3 | 3.41e-08 | 193 | 274 | 11 | ef2f456c094e6e3c6ee81e0668c953cb8d0e1c0a |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | BNC2 SYN3 MYO10 SVEP1 SRGAP1 NAV2 TBX5 COL5A2 ADAMTS8 PALLD MCOLN3 | 3.60e-08 | 194 | 274 | 11 | e93de9428c986b8943fc169258847c650cfab0e5 |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_adventitial_fibro_(9)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | BNC2 ABCA10 SVEP1 COL5A2 FAM13C APBB2 TEX15 RUNX1T1 PREX2 PLA2R1 CSGALNACT1 | 3.60e-08 | 194 | 274 | 11 | 99577a5a631e607b5abe7a1b0d8d6a5eabe50196 |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_adventitial_fibro_(9)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | BNC2 ABCA10 SVEP1 COL5A2 FAM13C APBB2 TEX15 RUNX1T1 PREX2 SBF2 CSGALNACT1 | 3.79e-08 | 195 | 274 | 11 | 70387a62f121f8c374dba1aca9ab65cfed6a0b10 |
| ToppCell | COVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type | BNC2 ABCA10 SVEP1 SRGAP1 NAV2 TBX5 COL5A2 RUNX1T1 PLA2R1 THBS2 TENM3 | 4.43e-08 | 198 | 274 | 11 | df3de77216f5c5d6141ec44d01c56b942f611838 |
| ToppCell | Tracheal-NucSeq-Stromal-Peri/Epineurial_-NAF_epineurial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | BNC2 KLF12 MAP2 ELFN2 ABCA10 ADCY3 SVEP1 COL5A2 MRAS RUNX1T1 SLC2A1 | 4.67e-08 | 199 | 274 | 11 | 9c2db0bb94cba71a3cc1827844da090e213e0258 |
| ToppCell | Parenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | BNC2 ABCA10 SVEP1 SRGAP1 TBX5 COL5A2 ADAMTS8 RUNX1T1 THBS2 TENM3 PALLD | 4.91e-08 | 200 | 274 | 11 | cf433f9b43d7db07acaf70e060f8f77c974e72f3 |
| ToppCell | Tracheal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | BNC2 ABCA10 SVEP1 NAV2 TBX5 COL5A2 COL11A1 RUNX1T1 PREX2 THBS2 TENM3 | 4.91e-08 | 200 | 274 | 11 | c318d14bd6fd6f42c597eb55ac9e2f48008aeb9b |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | BNC2 ABCA10 SVEP1 TMEM132C SRGAP1 NAV2 TBX5 COL5A2 RUNX1T1 THBS2 TENM3 | 4.91e-08 | 200 | 274 | 11 | cae972324d1dfea6efeaf6013f265c7c6bb48db4 |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | BNC2 ABCA10 SVEP1 SRGAP1 TBX5 COL5A2 ADAMTS8 RUNX1T1 THBS2 TENM3 PALLD | 4.91e-08 | 200 | 274 | 11 | 311fab076f2ceb258e3970eb21e39344b894042a |
| ToppCell | PND28-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-Treg-Treg_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | LVRN CDCA3 MYO3B PPP1R3F CAMK4 RNASEL LAT ASPRV1 FYB1 L3MBTL4 | 6.07e-08 | 160 | 274 | 10 | 8308ca6f37986c526432a0fbc5f7ec2e75cfb6d7 |
| ToppCell | droplet-Marrow-nan-3m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | CASZ1 SAMD9L MAP3K9 ARFGEF1 LIF CSF1R PCNX1 SSH2 PALLD GLIS1 | 1.41e-07 | 175 | 274 | 10 | cf53a15bfb37b6019e7052ffdf594a9ac040900e |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | PDXDC1 ADAM28 CASZ1 LIPH ZNF648 SRGAP1 ANK3 NPEPPS LMTK2 MFSD4A | 1.74e-07 | 179 | 274 | 10 | 6e965e424eebef50f0202cff75f458be395cfca1 |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | MAP2 CASZ1 KCNC4 MYO3B PPM1E KCNH3 IVNS1ABP RIMBP2 IRX2 CSGALNACT1 | 2.25e-07 | 184 | 274 | 10 | d33de57876817050b294f2ecb0a4eb0634cfa7f0 |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | MYO10 CYTH3 ADCY3 ADAMTS9 TBX5 FAM13C NTRK3 PREX2 CSF1R TJP1 | 2.61e-07 | 187 | 274 | 10 | 86250acf088ec0c4800a0dfa031b0d4f7e52c342 |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 2.61e-07 | 187 | 274 | 10 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | BNC2 SVEP1 TMEM132C SRGAP1 TBX5 COL5A2 ADAMTS8 RUNX1T1 THBS2 TENM3 | 3.17e-07 | 191 | 274 | 10 | b13229bb7f3713a392271aaf5dbae3edd1b9fe5a |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | BNC2 SVEP1 TMEM132C TBX5 COL5A2 ADAMTS8 RUNX1T1 THBS2 TENM3 PALLD | 3.33e-07 | 192 | 274 | 10 | 4e47a02007f562f29ba5910df64d32a0167d0bd1 |
| ToppCell | human_hepatoblastoma-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | CDCA3 RAD18 SYN3 CCDC18 C5orf34 RBL1 CEP192 MDC1 GSTCD ESPL1 | 3.49e-07 | 193 | 274 | 10 | 4b9fa2a4424f8abe63fa7bee78db93dda04ab15f |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | BNC2 MYO10 SVEP1 TMEM132C SRGAP1 TBX5 COL5A2 ADAMTS8 RUNX1T1 PALLD | 3.49e-07 | 193 | 274 | 10 | acad568621ed677031797b8c2e34dafea798d681 |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | BNC2 SVEP1 LURAP1L TMEM132C TBX5 COL5A2 ADAMTS8 RUNX1T1 TENM3 PALLD | 3.66e-07 | 194 | 274 | 10 | 6e13549f697f7478b34fe71f7dd9d63c5d3db22e |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D122|Adult / Lineage, Cell type, age group and donor | BNC2 SYN3 ABCA10 SVEP1 SRGAP1 NAV2 TBX5 COL5A2 ADAMTS8 PALLD | 3.84e-07 | 195 | 274 | 10 | aa0add081881d349099d12efca5cdee098038d4e |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell|Adult / Lineage, Cell type, age group and donor | BNC2 SYN3 SVEP1 SRGAP1 NAV2 TBX5 COL5A2 ADAMTS8 RUNX1T1 PALLD | 3.84e-07 | 195 | 274 | 10 | 61c9e09fc84d1012e472185d70ad0a06cee30d6e |
| ToppCell | human_hepatoblastoma-Inflammatory_Monocytes|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | BNC2 ITGAX SRGAP1 LILRB5 LILRB3 GPRIN3 LRRK1 CSF1R SIGLEC1 FYB1 | 3.84e-07 | 195 | 274 | 10 | ba7f85e5307d96ac5ad7c952f8d094db9ca1790c |
| ToppCell | nucseq-Mesenchymal-Fibroblastic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.03e-07 | 196 | 274 | 10 | 7d8505dac15fa59935ccf592afc54b04c4c6554f | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | CYTH3 SVEP1 SRGAP1 NAV2 COL5A2 APBB2 RUNX1T1 PREX2 TENM3 PALLD | 4.22e-07 | 197 | 274 | 10 | 85a8f1d18e0dd1d31341f5131eecd217553bf042 |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | BNC2 C8orf34 ABCA10 SVEP1 NAV2 TBX5 COL5A2 FAM13C RUNX1T1 PREX2 | 4.22e-07 | 197 | 274 | 10 | 0dd71e399f253787fa546a7e90c5373180b89ffd |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | CYTH3 SVEP1 SRGAP1 NAV2 COL5A2 APBB2 RUNX1T1 PREX2 TENM3 PALLD | 4.22e-07 | 197 | 274 | 10 | e8e3ba791dfaa0fab35e0329a5e34376f9ee6143 |
| ToppCell | COVID-19-lung-Fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | BNC2 SVEP1 LURAP1L SRGAP1 NAV2 TBX5 COL5A2 RUNX1T1 THBS2 TENM3 | 4.42e-07 | 198 | 274 | 10 | 3ec01a55ade5e1627258cc3cfebb2c3207a4cb43 |
| ToppCell | nucseq-Mesenchymal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.42e-07 | 198 | 274 | 10 | 8f52243ca8b9ba68a75ae411506a3a6de258eb97 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-Tfh|lymph-node_spleen / Manually curated celltypes from each tissue | 4.42e-07 | 198 | 274 | 10 | fbdd37ca3d4b61f266bf6146662cb300ef67b850 | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | BNC2 KLF12 HNRNPH1 PRRC2C RELCH ANK3 ARFGEF1 GPRIN3 SCML4 CCNT1 | 4.63e-07 | 199 | 274 | 10 | f0b0097df0026496470a80d8cc9375ffd8389b00 |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Myeloid-Macrophage_other-Macrophage_intravascular|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | ITGAX ADAM28 C3AR1 LILRB5 LILRB3 CRHBP TGFBI M1AP CSF1R SIGLEC1 | 4.85e-07 | 200 | 274 | 10 | 4b4df0fe47498310d94448b8a289e58e4f5b5aa8 |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | BNC2 ABCA10 SVEP1 TMEM132C NAV2 TBX5 COL5A2 RUNX1T1 PREX2 THBS2 | 4.85e-07 | 200 | 274 | 10 | b4ccffdd79526c85e5273d27b668dbddcddba1ee |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | BNC2 SVEP1 SRGAP1 TBX5 COL5A2 ADAMTS8 RUNX1T1 TENM3 PALLD MCOLN3 | 4.85e-07 | 200 | 274 | 10 | 34f52003988ce6329d8deeee1ab875fa77e01e9d |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Peri/Epineurial_|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | BNC2 CYTH3 ABCA10 EMSY COL11A1 MRAS MARCHF8 APBB2 SLC2A1 PLA2R1 | 4.85e-07 | 200 | 274 | 10 | 5ad3ea1cf1fcd4100966c5517bc7ed0a1af54317 |
| ToppCell | Bronchus_Control_(B.)-Stromal-TX-Fibroblasts-1|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | ABCA10 TMEM132C MYO3B COL5A2 NTRK3 ADAMTS8 RUNX1T1 PREX2 THBS2 GLIS1 | 4.85e-07 | 200 | 274 | 10 | 16a3685c41194a0a4a772e4eee372160263480e0 |
| ToppCell | PCW_07-8.5-Hematologic_Myeloid-Hem_Myeloid_macrophage-im_macrophage_(16)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 7.58e-07 | 162 | 274 | 9 | 2b47fd256490d0c2d9ad5950aa26410aeb6ec995 | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs-18m-Myeloid-neutrophil|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | TARM1 FSCN2 MAP3K9 LILRB3 LILRA6 IFNLR1 PPP1R3D TGFBI ASPRV1 | 8.84e-07 | 165 | 274 | 9 | 4fe7c3c9370a556cf4e308a2e723b4b907a6cc25 |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Hematologic-fibroblast|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.77e-07 | 167 | 274 | 9 | f5bffa77061baec0ba87bd688a047595f32534db | |
| ToppCell | 390C-Myeloid-Macrophage-SPP1+_Macrophage_4|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.13e-06 | 170 | 274 | 9 | 439167e44a1bd5ac8e1e457351dd202ec968db46 | |
| ToppCell | metastatic_Brain-B_lymphocytes-GrB-secreting_B_cells|B_lymphocytes / Location, Cell class and cell subclass | 1.58e-06 | 177 | 274 | 9 | 43e1d0d3cf8f0c02e67d91f8dd1761df23d59e07 | |
| ToppCell | wk_08-11-Mesenchymal-Chondrocyte-Resting_chondrocyte|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | CYTH3 ZIM2 PTHLH FHIP1A COL11A1 APBB2 MFSD4A TENM3 CSGALNACT1 | 1.99e-06 | 182 | 274 | 9 | 00a148b1e499bf16325491536d187d4dd6b70c06 |
| ToppCell | 367C-Fibroblasts-Fibroblast-D-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 2.09e-06 | 183 | 274 | 9 | b12b89debc9dd6396188bc8fe44f54c01c560966 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-D|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 2.09e-06 | 183 | 274 | 9 | 19cc0009f5332b6e4d4274df123eebbfc80b669a | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic-T_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.18e-06 | 184 | 274 | 9 | 8c23945bafe8926f25836bc208115edd5214a2b0 | |
| ToppCell | COVID-19-Fibroblasts-Pericytes|COVID-19 / group, cell type (main and fine annotations) | 2.28e-06 | 185 | 274 | 9 | 4905adaeeffd353e089578e5ea614437dbe794e6 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Hematopoietic-Myeloid|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.38e-06 | 186 | 274 | 9 | bec4767eaca28e41da373274704895eba75063e2 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | LURAP1L KCNC4 MYO3B NAV2 FHIP1A NPEPPS RIMBP2 EML1 CSGALNACT1 | 2.49e-06 | 187 | 274 | 9 | 42a1267bfc27b4460b8409ada580a87c4385841c |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | LURAP1L KCNC4 MYO3B NAV2 FHIP1A NPEPPS RIMBP2 EML1 CSGALNACT1 | 2.49e-06 | 187 | 274 | 9 | 64afdea159f5e67a1e5cea35ce898aae6e80aea5 |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D175|Adult / Lineage, Cell type, age group and donor | 2.49e-06 | 187 | 274 | 9 | e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | LURAP1L KCNC4 MYO3B NAV2 FHIP1A NPEPPS RIMBP2 EML1 CSGALNACT1 | 2.49e-06 | 187 | 274 | 9 | 87b3d0478693d4c54ff06b74e5903036b9c1ee6a |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.60e-06 | 188 | 274 | 9 | 2ee64bc73a2251fd9f374be759b442cf4ed0d19e | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.60e-06 | 188 | 274 | 9 | ee151792c7ac9afe820f1a281c6dab383799f358 | |
| ToppCell | 10x5'-Lung-Myeloid_Mac-Intestinal_macrophages|Lung / Manually curated celltypes from each tissue | 2.69e-06 | 141 | 274 | 8 | 7671d300b1722711fd2d8034b96a3aa7e3ccb560 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | BNC2 MYO10 SVEP1 TMEM132C SRGAP1 TBX5 COL5A2 ADAMTS8 RUNX1T1 | 2.72e-06 | 189 | 274 | 9 | 2a22b9fae70afb3dab8476f9c00e48a4df756410 |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.84e-06 | 190 | 274 | 9 | 45df8fee00f8949937863159d7aa042e72748d9b | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 2.84e-06 | 190 | 274 | 9 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | BNC2 C8orf34 ABCA10 COL5A2 NTRK3 PLA2R1 THBS2 TENM3 CSGALNACT1 | 2.84e-06 | 190 | 274 | 9 | 4f775ee24b14733f06ae40b45f2dc1a0f0df0705 |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.96e-06 | 191 | 274 | 9 | a6c57627077fa980b7ec1d3894b5f31bfb11b738 | |
| ToppCell | COVID-19-kidney-TAL|COVID-19 / Disease (COVID-19 only), tissue and cell type | KCNC4 MYO3B FHIP1A PPM1E SLC2A1 IVNS1ABP SHISA9 PPP2R3A RIMBP2 | 2.96e-06 | 191 | 274 | 9 | fe55475ce0666ab5122447a813dc2369e24947b8 |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.96e-06 | 191 | 274 | 9 | 8f6d592edc32fdb901af30501d4360512334e8c2 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.09e-06 | 192 | 274 | 9 | 4022f208eb5db760abd0aac782a25e8ab63efc64 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | RAPGEF6 HNRNPH1 CENATAC ANK3 CAMK4 ARFGEF1 GPRIN3 IVNS1ABP PCNX1 | 3.09e-06 | 192 | 274 | 9 | 47646d7e4990be85072987f92bf18d52f8da752e |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.09e-06 | 192 | 274 | 9 | 3d0cb19f037f604253d7d728689aeaa94251e92b | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | BNC2 SVEP1 TMEM132C SRGAP1 COL5A2 ADAMTS8 RUNX1T1 THBS2 TENM3 | 3.09e-06 | 192 | 274 | 9 | ee085e04d5dcfb657522484ed20b8c1ddeccfe0c |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.23e-06 | 193 | 274 | 9 | d1445b8bf2bab36e1a326ddb2a528151db016c7d | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.23e-06 | 193 | 274 | 9 | adc9fc94f9ec686a417d08c0b8b7b7ab687afec0 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 3.23e-06 | 193 | 274 | 9 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.23e-06 | 193 | 274 | 9 | b3ad5ff480d99217f36cc7471e5a96a519ddb409 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | BNC2 SVEP1 TMEM132C SRGAP1 TBX5 COL5A2 ADAMTS8 RUNX1T1 TENM3 | 3.23e-06 | 193 | 274 | 9 | fb28717fadd06c3840636d25409ce80c9254bd34 |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.23e-06 | 193 | 274 | 9 | e74fdc8718fe0933e1f4dd3fe37e2134983b99b6 | |
| ToppCell | COVID-19-Heart-Macrophage|Heart / Disease (COVID-19 only), tissue and cell type | 3.37e-06 | 194 | 274 | 9 | f09675cd472200363c458952f00d2e41990800ee | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | BNC2 SVEP1 TMEM132C SRGAP1 TBX5 COL5A2 ADAMTS8 RUNX1T1 TENM3 | 3.37e-06 | 194 | 274 | 9 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | BNC2 MYO10 SVEP1 TMEM132C SRGAP1 TBX5 COL5A2 ADAMTS8 RUNX1T1 | 3.37e-06 | 194 | 274 | 9 | 011e14d9ed1393275f892060e7708ffadcd0767f |
| ToppCell | Control-Fibroblasts-Intermediate_pathological_FB|Control / group, cell type (main and fine annotations) | BNC2 SVEP1 TMEM132C COL5A2 COL11A1 RUNX1T1 THBS2 TENM3 PALLD | 3.37e-06 | 194 | 274 | 9 | 03a269f75a481ea54aea8e6444605db8d6df493d |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | BNC2 SVEP1 TMEM132C SRGAP1 TBX5 COL5A2 ADAMTS8 RUNX1T1 TENM3 | 3.37e-06 | 194 | 274 | 9 | 60622bd2f75bfe4c37f721cb12f03dab33f2f58d |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.37e-06 | 194 | 274 | 9 | e03ba6caed59fa64d4d9b042593469d4a6a3dc10 | |
| ToppCell | 5'-Adult-SmallIntestine-Hematopoietic-Myeloid|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.51e-06 | 195 | 274 | 9 | f289a44010788853d7726d4b5aa75f3c62186c08 | |
| ToppCell | facs-Skin-nan-18m-Epithelial-outer_bulge|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | SVEP1 KIAA2012 COL5A2 FAM13C KCNH3 ARHGEF40 TENM3 LTBP3 PALLD | 3.51e-06 | 195 | 274 | 9 | ba7cb80deb872c9184769f0dd57855c3c6a432bf |
| ToppCell | PCW_05-06-Mesenchymal|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 3.66e-06 | 196 | 274 | 9 | dca52c57ba35d9395cdbca8b881f12ece721b10f | |
| ToppCell | Monocytes|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 3.66e-06 | 196 | 274 | 9 | ab0a8f5f388c9794d7f41f99fb0a5f2fd6fff6b3 | |
| ToppCell | Children_(3_yrs)-Mesenchymal|Children_(3_yrs) / Lineage, Cell type, age group and donor | BNC2 ABCA10 SVEP1 TMEM132C TBX5 COL5A2 ADAMTS8 RUNX1T1 PALLD | 3.66e-06 | 196 | 274 | 9 | bc94909f9b2dc08a59eef1914148b69720569c8f |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.82e-06 | 197 | 274 | 9 | 44673c38384453207871d3fd8e8ba9093cc06bc5 | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 3.82e-06 | 197 | 274 | 9 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | COPD-Stromal-Myofibroblast|World / Disease state, Lineage and Cell class | 3.82e-06 | 197 | 274 | 9 | d51f484b4e01ac64233950d0b97fa88825ea1dbb | |
| ToppCell | Bronchial_Brush-Immune|Bronchial_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 3.82e-06 | 197 | 274 | 9 | b78d277a1d80ef27c11593ffc68ff8a8abae111f | |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-Myeloid-Macrophages|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.82e-06 | 197 | 274 | 9 | e698a0bbb20bd4868ff4348f2ac9f609942b55fa | |
| ToppCell | COVID-19-Fibroblasts|COVID-19 / group, cell type (main and fine annotations) | 3.82e-06 | 197 | 274 | 9 | fb847f2277609c31fffcdf49517243ce0684facf | |
| Disease | Mitral valve prolapse, response to surgery | 2.89e-06 | 12 | 263 | 4 | EFO_0009951, HP_0001634 | |
| Disease | Early Pregnancy Loss | 6.26e-06 | 109 | 263 | 8 | C3830362 | |
| Disease | Spontaneous abortion | 6.26e-06 | 109 | 263 | 8 | C0000786 | |
| Disease | Miscarriage | 6.26e-06 | 109 | 263 | 8 | C4552766 | |
| Disease | Abortion, Tubal | 6.26e-06 | 109 | 263 | 8 | C0000822 | |
| Disease | Mitral valve prolapse | 1.63e-05 | 36 | 263 | 5 | HP_0001634 | |
| Disease | open-angle glaucoma | 5.82e-05 | 191 | 263 | 9 | EFO_0004190 | |
| Disease | sexual dimorphism measurement | PDXDC1 RAPGEF6 EPPK1 KMT2B SYN3 TSC2 CNBD2 ADCY3 ADAM28 PTHLH ZPR1 RAB43 SEC16A PLEC LILRB5 RBL1 NPEPPS ZNF322 SIPA1 TH ARHGEF40 ZNF592 LTBP3 CSGALNACT1 | 6.02e-05 | 1106 | 263 | 24 | EFO_0021796 |
| Disease | brain measurement, neuroimaging measurement | PDXDC1 MAP2 GPATCH8 ADAMTS9 DHFR NAV2 PLEC COL5A2 COL11A1 ANK3 GPATCH1 ADAMTS8 RUNX1T1 EML1 SSH2 | 1.39e-04 | 550 | 263 | 15 | EFO_0004346, EFO_0004464 |
| Disease | IGFBP-1 measurement | 1.87e-04 | 13 | 263 | 3 | EFO_0005118 | |
| Disease | electrocardiography | EPS15 KLF12 GOLM2 ADAR CASZ1 NAV2 PLEC TBX5 USP50 RPGRIP1 ZNF592 TKT PCNX1 PALLD | 3.20e-04 | 530 | 263 | 14 | EFO_0004327 |
| Disease | QRS duration | 3.71e-04 | 298 | 263 | 10 | EFO_0005055 | |
| Disease | Malignant neoplasm of prostate | ADAM28 PTHLH CASZ1 HNRNPH1 SDF2L1 RPRD2 NOL8 USP28 LMTK2 ADAMTS8 PALB2 IVNS1ABP RNASEL GSTCD SPEN | 4.64e-04 | 616 | 263 | 15 | C0376358 |
| Disease | Prostatic Neoplasms | ADAM28 PTHLH CASZ1 HNRNPH1 SDF2L1 RPRD2 NOL8 USP28 LMTK2 ADAMTS8 PALB2 IVNS1ABP RNASEL GSTCD SPEN | 4.64e-04 | 616 | 263 | 15 | C0033578 |
| Disease | mosaic variegated aneuploidy syndrome (is_implicated_in) | 4.69e-04 | 4 | 263 | 2 | DOID:0080688 (is_implicated_in) | |
| Disease | Disorder of eye | 6.65e-04 | 212 | 263 | 8 | C0015397 | |
| Disease | creatine kinase m-type:creatine kinase b-type heterodimer measurement | 7.78e-04 | 5 | 263 | 2 | EFO_0020292 | |
| Disease | Intervertebral disc disorder | 7.78e-04 | 5 | 263 | 2 | cv:C0158252 | |
| Disease | Lumbar disc disease | 7.78e-04 | 5 | 263 | 2 | C0221775 | |
| Disease | transmembrane protein 132C measurement | 7.78e-04 | 5 | 263 | 2 | EFO_0802152 | |
| Disease | INTERVERTEBRAL DISC DISEASE | 7.78e-04 | 5 | 263 | 2 | 603932 | |
| Disease | Mood Disorders | 8.07e-04 | 168 | 263 | 7 | C0525045 | |
| Disease | Salivary Gland Neoplasms | 8.14e-04 | 47 | 263 | 4 | C0036095 | |
| Disease | Dystonia | 1.05e-03 | 86 | 263 | 5 | C0013421 | |
| Disease | leukocyte immunoglobulin-like receptor subfamily B member 3 measurement | 1.16e-03 | 6 | 263 | 2 | EFO_0802705 | |
| Disease | Intervertebral disc disorder | 1.16e-03 | 6 | 263 | 2 | C0158252 | |
| Disease | leukocyte immunoglobulin-like receptor subfamily A member 6 measurement | 1.16e-03 | 6 | 263 | 2 | EFO_0801767 | |
| Disease | macrophage colony-stimulating factor 1 receptor measurement | 1.16e-03 | 6 | 263 | 2 | EFO_0020547 | |
| Disease | osteoarthritis, hip | 1.42e-03 | 92 | 263 | 5 | EFO_1000786 | |
| Disease | cholesteryl ester 16:2 measurement | 1.61e-03 | 7 | 263 | 2 | EFO_0021435 | |
| Disease | infertility (implicated_via_orthology) | 1.61e-03 | 7 | 263 | 2 | DOID:5223 (implicated_via_orthology) | |
| Disease | Colorectal Carcinoma | ELOA2 MAP2 C8orf34 ABCA10 HOXC9 DHFR ABCD3 RELCH PPM1E ARFGEF1 ERI2 RUNX1T1 PREX2 ARNT CTBP1 | 1.71e-03 | 702 | 263 | 15 | C0009402 |
| Disease | susceptibility to rheumatic fever measurement | 1.94e-03 | 28 | 263 | 3 | EFO_0008416 | |
| Disease | femoral neck bone mineral density | 1.96e-03 | 196 | 263 | 7 | EFO_0007785 | |
| Disease | fatty acid measurement | PDXDC1 MYO10 TMEM132C ZPR1 MYO3B PINX1 NRBF2 FAM13C ZNF322 SHISA9 CSGALNACT1 | 1.98e-03 | 436 | 263 | 11 | EFO_0005110 |
| Disease | hemorrhoid | 2.10e-03 | 147 | 263 | 6 | EFO_0009552 | |
| Disease | helping behavior measurement | 2.14e-03 | 8 | 263 | 2 | EFO_0008538 | |
| Disease | mammographic density percentage | 2.16e-03 | 29 | 263 | 3 | EFO_0006502 | |
| Disease | type 2 diabetes mellitus (implicated_via_orthology) | 2.53e-03 | 105 | 263 | 5 | DOID:9352 (implicated_via_orthology) | |
| Disease | temporal lobe epilepsy (biomarker_via_orthology) | 2.62e-03 | 31 | 263 | 3 | DOID:3328 (biomarker_via_orthology) | |
| Disease | Pancreatic carcinoma, familial | 2.73e-03 | 9 | 263 | 2 | C2931038 | |
| Disease | white matter microstructure measurement | 2.79e-03 | 390 | 263 | 10 | EFO_0005674 | |
| Disease | Large cell carcinoma of lung | 2.87e-03 | 32 | 263 | 3 | C0345958 | |
| Disease | Ciliopathies | 3.10e-03 | 110 | 263 | 5 | C4277690 | |
| Disease | triglyceride measurement, high density lipoprotein cholesterol measurement | 3.34e-03 | 274 | 263 | 8 | EFO_0004530, EFO_0004612 | |
| Disease | Delirium | 3.40e-03 | 10 | 263 | 2 | C0011206 | |
| Disease | heart function measurement | 3.42e-03 | 34 | 263 | 3 | EFO_0004311 | |
| Disease | Spinocerebellar Ataxia Type 2 | 3.42e-03 | 34 | 263 | 3 | C0752121 | |
| Disease | Spinocerebellar Ataxia Type 1 | 3.42e-03 | 34 | 263 | 3 | C0752120 | |
| Disease | Spinocerebellar Ataxia Type 5 | 3.42e-03 | 34 | 263 | 3 | C0752123 | |
| Disease | Spinocerebellar Ataxia Type 7 | 3.42e-03 | 34 | 263 | 3 | C0752125 | |
| Disease | Spinocerebellar Ataxia Type 6 (disorder) | 3.42e-03 | 34 | 263 | 3 | C0752124 | |
| Disease | Ataxia, Spinocerebellar | 3.42e-03 | 34 | 263 | 3 | C0087012 | |
| Disease | neutrophil percentage of leukocytes | KLF12 EMSY HNRNPH1 TYK2 PINX1 C3AR1 LBHD1 MARCHF8 SLC2A1 SCML4 PPP2R3A AATK CSF1R | 3.49e-03 | 610 | 263 | 13 | EFO_0007990 |
| Disease | cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement | 3.49e-03 | 276 | 263 | 8 | EFO_0004612, EFO_0020943 | |
| Disease | right ventricular systolic volume measurement | 3.71e-03 | 35 | 263 | 3 | EFO_0021815 | |
| Disease | Spinocerebellar Ataxia Type 4 | 3.71e-03 | 35 | 263 | 3 | C0752122 | |
| Disease | periodontitis | 4.01e-03 | 223 | 263 | 7 | EFO_0000649 | |
| Disease | total cholesterol measurement, very low density lipoprotein cholesterol measurement | 4.11e-03 | 224 | 263 | 7 | EFO_0004574, EFO_0008317 | |
| Disease | Cleft palate, tobacco smoke exposure measurement, cleft lip, parental genotype effect measurement | 4.13e-03 | 11 | 263 | 2 | EFO_0003959, EFO_0005939, EFO_0009115, HP_0000175 | |
| Disease | high density lipoprotein particle size measurement | 4.31e-03 | 170 | 263 | 6 | EFO_0008592 | |
| Disease | cortical surface area measurement | BNC2 INTU RELN MAP2 PTHLH SVEP1 HNRNPH1 ADAMTS9 PRRC2C DHFR NAV2 CACNA1A COL5A2 COL11A1 ANK3 MCPH1 RUNX1T1 ARHGAP1 TJP1 MDC1 EML1 SSH2 | 4.73e-03 | 1345 | 263 | 22 | EFO_0010736 |
| Disease | level of Phosphatidylinositol (16:0_18:1) in blood serum | 4.92e-03 | 12 | 263 | 2 | OBA_2045152 | |
| Disease | level of Phosphatidylinositol (18:0_20:3) in blood serum | 4.92e-03 | 12 | 263 | 2 | OBA_2045157 | |
| Disease | Amelogenesis Imperfecta | 4.92e-03 | 12 | 263 | 2 | C0002452 | |
| Disease | non-high density lipoprotein cholesterol measurement | BNC2 KLF12 FXYD5 TYK2 ZPR1 SPTY2D1 CACNA1A MARCHF8 NPEPPS ST3GAL4 DENND4C ENAM CSF1R PROX2 | 5.08e-03 | 713 | 263 | 14 | EFO_0005689 |
| Disease | cardiac troponin I measurement | 5.09e-03 | 176 | 263 | 6 | EFO_0010071 | |
| Disease | ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis | 5.19e-03 | 295 | 263 | 8 | EFO_0000384, EFO_0000676, EFO_0000729, EFO_0003898, EFO_0004268 | |
| Disease | neutrophil measurement | 5.23e-03 | 177 | 263 | 6 | EFO_0803548 | |
| Disease | cholesteryl ester 18:3 measurement | 5.42e-03 | 40 | 263 | 3 | EFO_0010346 | |
| Disease | cup-to-disc ratio measurement | BNC2 ELFN2 AMOTL1 NAV2 COL11A1 ANK3 NCKIPSD ADAMTS8 LTBP3 SYMPK | 5.51e-03 | 430 | 263 | 10 | EFO_0006939 |
| Disease | dihomo-linolenoylcarnitine (C20:3n3 or 6) measurement | 5.79e-03 | 13 | 263 | 2 | EFO_0800547 | |
| Disease | extracellular matrix protein 1 measurement | 5.79e-03 | 13 | 263 | 2 | EFO_0008126 | |
| Disease | retinitis pigmentosa (is_implicated_in) | 5.81e-03 | 41 | 263 | 3 | DOID:10584 (is_implicated_in) | |
| Disease | liver fat measurement | 6.64e-03 | 43 | 263 | 3 | EFO_0010821 | |
| Disease | reticulocyte measurement | BNC2 FXYD5 UBAP1 ITGAX BIRC6 ADCY3 PTHLH ZPR1 RAB43 NRBF2 MARCHF8 UPRT SIPA1 SLC2A1 SBF2 PRKAA1 SIGLEC1 ASPRV1 | 6.66e-03 | 1053 | 263 | 18 | EFO_0010700 |
| Disease | Autosomal recessive limb-girdle muscular dystrophy | 6.71e-03 | 14 | 263 | 2 | cv:C2931907 | |
| Disease | response to methotrexate, aspartate aminotransferase measurement | 6.71e-03 | 14 | 263 | 2 | EFO_0004736, GO_0031427 | |
| Disease | respiratory quotient | 6.71e-03 | 14 | 263 | 2 | EFO_0005189 | |
| Disease | pulse pressure measurement | BNC2 UBAP1 GPATCH8 PTHLH CASZ1 SVEP1 PINX1 CEP97 TBX5 USP50 COL11A1 ST3GAL4 ADAMTS8 SIPA1 DENND4C THBS2 LATS2 SBF2 LTBP3 EML1 CDC25A PALLD | 6.99e-03 | 1392 | 263 | 22 | EFO_0005763 |
| Disease | JT interval | 7.07e-03 | 248 | 263 | 7 | EFO_0007885 | |
| Disease | concentration of large LDL particles measurement | 7.08e-03 | 44 | 263 | 3 | EFO_0022160 | |
| Disease | schizophrenia (is_marker_for) | 7.08e-03 | 44 | 263 | 3 | DOID:5419 (is_marker_for) | |
| Disease | very long-chain saturated fatty acid measurement | 7.08e-03 | 44 | 263 | 3 | EFO_0006796 | |
| Disease | cholesteryl ester 20:4 measurement | 7.08e-03 | 44 | 263 | 3 | EFO_0010348 | |
| Disease | cholesterol in medium VLDL measurement | 7.08e-03 | 44 | 263 | 3 | EFO_0022225 | |
| Disease | alanine measurement | 7.40e-03 | 86 | 263 | 4 | EFO_0009765 | |
| Disease | Malignant neoplasm of salivary gland | 7.54e-03 | 45 | 263 | 3 | C0220636 | |
| Disease | QRS complex, QRS duration | 7.54e-03 | 45 | 263 | 3 | EFO_0005054, EFO_0005055 | |
| Disease | eosinophil count | BNC2 KLF12 RAPGEF6 CCDC18 EMSY SVEP1 PTPN2 ZPR1 SEC16A PLEC KIAA2012 USP50 NCKIPSD FBXO46 CEP43 PLA2R1 GRPEL1 RESF1 SBF2 UNK PCNX1 LTBP3 SYMPK | 7.58e-03 | 1488 | 263 | 23 | EFO_0004842 |
| Disease | neuroimaging measurement | PDXDC1 RELN KMT2B MAP2 RBM26 TYK2 PRRC2C DHFR NAV2 PLEC COL5A2 COL11A1 ANK3 MCPH1 RUNX1T1 DENND4C EML1 SSH2 | 7.72e-03 | 1069 | 263 | 18 | EFO_0004346 |
| Disease | Abnormality of refraction | CDCA3 KLF12 SYN3 BIRC6 ADAMTS9 PINX1 RPGRIP1 ANK3 ST3GAL4 LATS2 EXD2 RIMBP2 GLIS1 | 7.77e-03 | 673 | 263 | 13 | HP_0000539 |
| Disease | lifestyle measurement, anxiety disorder measurement | 7.80e-03 | 137 | 263 | 5 | EFO_0007795, EFO_0010724 | |
| Disease | oropharynx cancer | 8.01e-03 | 46 | 263 | 3 | EFO_1001931 | |
| Disease | Malignant neoplasm of breast | ATP6V0B ADAR FSCB PTHLH EMSY C5orf34 OTOF KCNH1 DHFR COL11A1 PPM1E SLC2A1 PALB2 THOC5 CSF1R PRKAA1 ZFYVE26 SPEN | 8.08e-03 | 1074 | 263 | 18 | C0006142 |
| Disease | free cholesterol in small VLDL measurement | 8.50e-03 | 47 | 263 | 3 | EFO_0022272 | |
| Disease | free cholesterol in medium VLDL measurement | 8.50e-03 | 47 | 263 | 3 | EFO_0022269 | |
| Disease | Ataxia, Motor | 8.75e-03 | 16 | 263 | 2 | C0278161 | |
| Disease | shigellosis | 8.75e-03 | 16 | 263 | 2 | EFO_0005585 | |
| Disease | Diabetic Angiopathies | 8.75e-03 | 16 | 263 | 2 | C0011875 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PSADEFADHLGNSKL | 496 | A8MVM7 | |
| LNSVFKDGTPPIDAH | 416 | Q15582 | |
| KHSVDATFENQGPSP | 1466 | O00555 | |
| PEHSKPLEKSDGLFA | 536 | P27540 | |
| DPGSDISAFKLPEHK | 491 | A8K979 | |
| PGHDKPFSVNETRDK | 146 | P60509 | |
| GDKDFPPAAAQVAHQ | 66 | P51397 | |
| HSKLFEEPEDPSNRS | 261 | Q9Y2T4 | |
| AGAAPTKEELATFDP | 51 | O95445 | |
| HLPNSGEAIPADGKS | 956 | Q96N23 | |
| EPNGSKFAVLHGEAP | 571 | P55884 | |
| DSAPLSPGDKEDASH | 396 | Q8TER5 | |
| HAATVNPDPSLKEFE | 371 | Q92870 | |
| IADFPNHTAPSEKRD | 786 | Q75V66 | |
| HDITGAPPLSSLEKD | 2466 | Q9NR09 | |
| PSLSGQAKPEDSDCH | 586 | Q8WY36 | |
| VHESEPFSFSQGPLK | 291 | Q13363 | |
| SPPEKTQADLLAFLH | 111 | Q8TDX6 | |
| DSFEPVSPEFHGKEA | 376 | Q8WWZ4 | |
| DLPVEGNEPPASFHK | 736 | Q9UKQ2 | |
| GNEPPASFHKDTNAL | 741 | Q9UKQ2 | |
| ESAHKAEAPALPGSL | 1001 | Q6ZN30 | |
| PPSLLGAKDTEHEES | 706 | Q86V15 | |
| HTEECPPDGKSFREQ | 576 | Q9UP79 | |
| AETEKQSPPHGEAKA | 46 | Q9Y6D6 | |
| NDKASSPGHPAFLED | 301 | Q9C073 | |
| LHSPDEKIPDSFDSL | 431 | Q49A92 | |
| PPTHAQGIAKSESED | 441 | Q86UB2 | |
| HPAAKGTAEKLENSP | 911 | Q8IY63 | |
| ASFPGHNVKVTVEDP | 726 | O60306 | |
| LPKLEPLGETHHNDF | 391 | Q3SXY8 | |
| KIEHPLDPNSEEGSA | 31 | Q9H9E1 | |
| PSEETGGAVFDHPAK | 576 | O60563 | |
| PSALVFDLHVSPEDG | 2326 | Q96M86 | |
| PKTDIIALPSFDNHA | 366 | Q6Q4G3 | |
| DVQTDPQTLKPSGFH | 116 | Q96DB9 | |
| SGFPIEDHETSPLDN | 271 | Q16581 | |
| FVQVKDLPDGHAASP | 321 | Q9P1Y5 | |
| EGLKHAQDSDPRSPT | 56 | Q99618 | |
| KAEQDASIPPGTHEA | 146 | Q9UGP5 | |
| LEPEVFHLNPAKSDT | 171 | P23786 | |
| APFPHGDSALNEQEK | 131 | Q96S59 | |
| SAKDPPLNVDKAFHD | 156 | O14807 | |
| EQPSSGSLKVEFFPH | 86 | Q5T8P6 | |
| HFSQSKLDSPEELEP | 401 | Q9NS91 | |
| GPLFSEKSPDHIQLN | 186 | Q86YS6 | |
| GVKAEFAAPSTDAPD | 61 | Q96B26 | |
| EKIAPPASDFLAHIQ | 1001 | P20702 | |
| PKGHHVTDSENDEPL | 61 | Q96ST2 | |
| ELSKEDLSPAFDHSP | 291 | P17706 | |
| PHGPSEARNTDTLDK | 866 | Q9ULD8 | |
| FKNGVAQEPVHLDSP | 61 | P04217 | |
| PLSKAPENEHFLGAA | 206 | O95170 | |
| LPHKDSEDSGQHPDV | 411 | Q9P260 | |
| EPHKFAALQKLDDPG | 196 | Q6W4X9 | |
| SNDRETQEGKPPTAH | 341 | Q8IYF1 | |
| ENLLKHFIPGTTDPA | 161 | Q5JU00 | |
| TLPSPEADALAGSKH | 156 | P31274 | |
| VRAHSEKDQPPFGDS | 481 | Q14676 | |
| FPLLPEDPHDDSLKN | 411 | Q8TC57 | |
| SYTIEDPALPKGHDD | 526 | Q8NEM0 | |
| HQESLPPPEFSKDSG | 421 | Q8IU57 | |
| DEPFHIGTPAENKLN | 191 | Q8TDD5 | |
| EKEDASSLPPKFQSH | 271 | Q8N468 | |
| DPHGISHVKFDDLNP | 66 | Q9Y6Y0 | |
| INGHFLKEPFPESTD | 391 | Q16288 | |
| SSGKIFASEHPEFQP | 186 | Q5H9T9 | |
| GASQSDKTPEELFHP | 471 | P11166 | |
| DKTPEELFHPLGADS | 476 | P11166 | |
| APAPAAEGLDAKEEH | 476 | Q9NRM7 | |
| NGFDREPLHSEHPSK | 251 | Q06455 | |
| PKHFPSEDSDLAGEA | 1601 | Q86WG5 | |
| HTANPKVPEGDSIAD | 1801 | Q38SD2 | |
| HQESDSLGEPAVPHK | 2371 | Q9UKN7 | |
| EEDFPSLNPEAGKQH | 156 | Q9HC44 | |
| EALFHTPVEGKEPGT | 176 | Q9HAV7 | |
| ESHKASRDPSPIQDG | 351 | Q16566 | |
| ELHPGAAKTEPAALS | 226 | O43561 | |
| VTDFPPFHANGTEKA | 86 | P15018 | |
| SHLLPPNSFEGAEEE | 196 | Q9BQE6 | |
| FPVDHKGVLSGAEAP | 291 | Q5VYM1 | |
| VFLFEDHTGKPAPED | 136 | P12107 | |
| TCKDLQLSHPDFPDG | 1606 | P12107 | |
| PFSRNSPGEKNDDHS | 261 | Q9NVH0 | |
| DVTPVDFTPKDNVHG | 221 | Q9BRR8 | |
| DGDNTTHPKNAPESK | 421 | Q9UKJ3 | |
| VLKHTGPNSPDTAND | 96 | P55795 | |
| NSGVHEAKDPTPSDE | 461 | Q96RV3 | |
| TPESNKDGVFSLDPD | 2731 | Q9NYQ8 | |
| VAHFEAQRDSPPTKG | 231 | Q6PJ61 | |
| TDQTEAFQKGVPHPE | 761 | Q6P996 | |
| KASAQDAGDHVQPPE | 271 | Q96BK5 | |
| DDPDIHEKPFLSSSA | 856 | Q32MH5 | |
| ENKDHAGEISSLPFP | 246 | O15117 | |
| GHPDDEFESETPNFK | 156 | Q969I3 | |
| EHNLRPFGKDEDTPH | 91 | Q14D04 | |
| PFGKDEDTPHAKIAS | 96 | Q14D04 | |
| KHEADANPRAGLIPS | 276 | Q5T2T1 | |
| KSHIAEGPADLEDPF | 306 | Q9NUL7 | |
| DDAFKDSPNPSEHGH | 1001 | Q9HD67 | |
| DGSPNLDFKPEDQPH | 151 | Q9UMX5 | |
| SGVPDHAKLQAPGSE | 806 | O95259 | |
| EGPSSQHFLKANTEP | 636 | Q0VF49 | |
| EKSPLTEPNFENKHG | 251 | Q5T0T0 | |
| SSLPELGQELHNKPF | 916 | Q8IWU2 | |
| APVELFSKDQSFPEH | 66 | Q8NA19 | |
| DTFFLTKEGAAHPPL | 351 | O75023 | |
| GKDPAAFSHLEDPRQ | 1566 | Q9UMN6 | |
| GKPHQDRLDPSDAQF | 186 | Q8WWY8 | |
| FDTFLLTKEGAAHPP | 351 | Q6PI73 | |
| FDTFLLTKEGAAHPP | 351 | O75022 | |
| KQDPFQESGLHLSPT | 291 | Q15599 | |
| PADRKSNDLFPEHGF | 166 | Q6ZWI9 | |
| VLKHTGPNSPDTAND | 96 | P31943 | |
| HSSDFLLEPPGHNKE | 236 | Q9NPJ6 | |
| NALANLDGHPEDKPT | 781 | Q76FK4 | |
| VDTHPGLTFLKDAPE | 826 | Q06190 | |
| APGEALHTAPKAASD | 416 | Q9BZI1 | |
| SHKPSAEDAEGQSPL | 101 | Q96F24 | |
| APGSKDHTPSQELAL | 341 | Q86U44 | |
| PSILKDDFNGNLHPD | 1801 | P78509 | |
| EASKPHSAQFLLPVE | 576 | Q8WY54 | |
| DGFSPHTTPDAVRKQ | 726 | Q9ULD6 | |
| AAIDNGLAFPFKHPD | 341 | Q8TCG2 | |
| LDIKAAFQPEANPSH | 1356 | Q8WX93 | |
| EHFPHRVSDPSGEQK | 126 | Q86YC2 | |
| HQESEKPSFLPSGAP | 206 | Q3B8N5 | |
| LLPTDDFLGHEDPKS | 281 | Q9P2D7 | |
| DDGFCSSHPKPSNRE | 976 | Q9P2N4 | |
| PADDPTASHINPQKD | 561 | Q711Q0 | |
| PFSDHQPEPKLANAT | 341 | P07333 | |
| NSDPFHSEPKEPKQE | 701 | Q05DH4 | |
| ALESGHFPQPEKESF | 1681 | Q14674 | |
| SHKASPEDGQEGLPQ | 1691 | Q9Y6J0 | |
| AAEFKLVDQSGPPHE | 741 | P55265 | |
| EGALDLSDVHSPPKS | 146 | O95684 | |
| DKIGPVDHIEFSSGP | 2736 | Q9H799 | |
| EKFPSSQDHPLPSAE | 121 | P24387 | |
| SGHEKAEDIKFLPAP | 1306 | Q5T9S5 | |
| QEKSLPEFPDSGFHS | 691 | Q8IW35 | |
| AEKAHAASPGDSPVF | 401 | Q495W5 | |
| KNHIPVFSPALTDGS | 226 | P49366 | |
| DENAPGSPSFDQPHK | 506 | Q9H972 | |
| KEPPQGAHFLSRSLD | 81 | P00374 | |
| EPFKIPEDDGNDLTH | 241 | Q99418 | |
| SFAHEDKNSPPKEEG | 621 | P57058 | |
| QAQGLDPPTHHFELK | 671 | Q5T0F9 | |
| EPFKIPEDDGNDLTH | 246 | O43739 | |
| LDHGSPAQENPESEK | 1281 | Q5VZ89 | |
| GHPDDELESETPNFK | 156 | A0A0U1RQE8 | |
| PALIETKEPNGSAHS | 526 | O60266 | |
| SPDDFSQHDQDKSPL | 2111 | Q12955 | |
| AAPDDKNKTDPGVHA | 1256 | P05997 | |
| LADDVPGHQTPSDLD | 186 | Q8IV03 | |
| PLAPEGDSVASKHAI | 171 | Q9NS15 | |
| VPEQGSHFSVDPKNL | 1686 | Q8TEP8 | |
| LSEEENLLPGTPDFH | 71 | Q13118 | |
| VKGEPPEDSLSVDHF | 61 | Q9Y4X4 | |
| TPLKAAQHDLPASEG | 81 | O75449 | |
| KLPPDRVGANFDHSS | 276 | Q86UT8 | |
| QHSETQGAEKPDPES | 61 | O75208 | |
| HNASLPVPAETGSKE | 126 | Q7Z589 | |
| KSINVDPLDADEHSP | 1106 | Q9NRM1 | |
| KIIEDPAQSSGFHPS | 581 | O00423 | |
| ETLKHNDPFAPGGTV | 686 | P42566 | |
| KQEPADEFSELFGPH | 146 | Q8NBF1 | |
| PQESPSKETLEAHGA | 101 | Q7Z2K8 | |
| KEDDLGEPQAASPRH | 21 | Q6ZVF9 | |
| GSEFLFEKSPPVSAH | 31 | Q96MH7 | |
| DSLPISPDDGQHADI | 666 | Q92622 | |
| ASRKPSDDKHFGQAP | 1016 | Q5VT52 | |
| KASDLPPLEHVFAEG | 266 | Q8NEC7 | |
| GEVKAFFESHPAPSA | 866 | P55786 | |
| EKANGLSTPSESPHF | 621 | P80192 | |
| GASPKESTNPEKAHE | 296 | P30304 | |
| ATDLHPADINGKADP | 1501 | Q9HC10 | |
| PGKDELFDLEESHPQ | 246 | O14926 | |
| EKETGPPEHDLDAAS | 556 | Q9H1H9 | |
| TSKPPFHELGEPQAA | 846 | Q6ZN16 | |
| SAPRHQEEDKPEAAG | 216 | Q9UBD0 | |
| FDENESPVDPQHGSK | 361 | Q6P4E1 | |
| HAPQELPQAKGSDDE | 186 | Q96JB3 | |
| HSLGPEKFPLVEQTF | 216 | O14994 | |
| EGPPFSTHQVDANIK | 506 | Q4G112 | |
| HSFVESANENALKPP | 1306 | O75445 | |
| PLASSGVPETKDEHL | 601 | O15034 | |
| KPDTSDHQVSLPQGA | 286 | Q8NC24 | |
| ELSSAIHELFPTGPK | 481 | Q8IWZ5 | |
| QPFHPKLGDVTDADS | 1576 | Q8TEU7 | |
| DPDQGHLKFTVVSDP | 1201 | Q96KN7 | |
| GFNDHKPLDPETIAQ | 946 | Q7Z6B7 | |
| SLPKSHLEPSLEEGF | 481 | Q93075 | |
| PNVTGPADLKHFDPE | 311 | Q9HBY8 | |
| DFTNFPAHVDLPKAG | 891 | Q8N3T6 | |
| EGFGLAHTPLEPDAK | 6 | Q99593 | |
| HTDPEALKGFHIDPE | 306 | Q6ZQX7 | |
| ALKGFHTDPNAEEAP | 391 | Q6ZQX7 | |
| SGGDHPQAEPKLATE | 771 | Q6ZMQ8 | |
| EHSNSKGEETPLGFP | 361 | P0C2Y1 | |
| DLLNPSFKGLPSDFH | 221 | P28749 | |
| PVPDSFFAKHLQTGE | 181 | O94906 | |
| PPDGKSHFPELQDDS | 1241 | Q9HCM1 | |
| SHFPELQDDSRKDTP | 1246 | Q9HCM1 | |
| DPGQLDNSKPSKTEH | 86 | Q8IVG5 | |
| GHSFKTPGPLEAFEE | 146 | O15353 | |
| KDLGNPPLASESTHE | 206 | O60921 | |
| PSDDTKGFFDPNTHE | 1721 | P58107 | |
| PSDDTKGFFDPNTHE | 3446 | P58107 | |
| LAHPSDDTKGFFDPN | 4511 | P58107 | |
| DPSDDTKGFFDPNTH | 5046 | P58107 | |
| VEPSHFTKTGQPALE | 721 | Q8IVL1 | |
| KFLLDHQGELFPSPD | 421 | Q07960 | |
| HTQKPDEQRSEPSAG | 931 | Q9Y520 | |
| LSHGAKEDFHPPAED | 321 | Q05823 | |
| DEKPNPGLSKDITHF | 181 | Q8IYI0 | |
| ESAHFDPKVENNPDT | 171 | Q11206 | |
| DAEPEPGNLSEKVSH | 966 | Q96FS4 | |
| DEPRAFSPEHGPAKQ | 331 | B4DS77 | |
| HPEESPLGAKFQLSL | 226 | Q8IX21 | |
| EAAQVHGVKDPAPAS | 171 | Q8NE31 | |
| SADPSPVHKDGQNEA | 196 | Q8NE31 | |
| PVHKDGQNEADSAPE | 201 | Q8NE31 | |
| ASDSNPAGPLRDKVH | 131 | Q9BUU2 | |
| SQPSLREGHDKPVFN | 296 | Q68D10 | |
| EPPKVENGFLEHTTG | 2206 | Q4LDE5 | |
| ELGALPHSATAEEKP | 211 | A6NEL2 | |
| ADIHTAEALPEKGPS | 1381 | Q13018 | |
| PHSVLKFLQDVFGSP | 611 | Q9NZQ3 | |
| KFDHVPLATPNGDVL | 441 | P28288 | |
| GTLPFDDDHVPTLFK | 221 | Q13131 | |
| GSLPEDHFSELPQVD | 886 | Q8IWZ3 | |
| GAAPSHLPKEIVFAN | 176 | Q53RT3 | |
| PRHAGSVKPEASEAF | 606 | Q0VD83 | |
| DFIAEEGHFPPKAIQ | 76 | Q96M20 | |
| DEDGSSAFLDPHPKL | 166 | Q96M20 | |
| SVDASKEDLHPADPQ | 6 | Q32M92 | |
| KGPDNAEAPETLALH | 171 | Q32MQ0 | |
| GNSFVENPHAPQKDD | 201 | O75312 | |
| RKPFPINHGETSDET | 186 | P15374 | |
| FDNTIKEHFPEGSRP | 221 | Q6NUS8 | |
| SPPHIKADFNLADFE | 146 | Q9NZ09 | |
| LSQDTPEEDPRGKHA | 141 | Q9HBT7 | |
| KNSAADLEHPEPSLP | 1881 | Q96T58 | |
| EGLAPEDRDKPAHQA | 2196 | Q96T58 | |
| DLDGHPVPKQAFTDV | 106 | P29401 | |
| AFPGPLAKDDTHKVD | 1496 | O15027 | |
| LPTPFKTNGQEDHAT | 286 | Q96PX8 | |
| KGKSDEAPPEHSFVL | 911 | Q76I76 | |
| IFIKPSVEPSAGHDE | 206 | Q9HCN8 | |
| KLTEFHGAFPDAQLP | 626 | Q9Y5W7 | |
| KHTDPQISGPLADLF | 641 | Q9UQR0 | |
| EPFSATDPKAIGHRN | 116 | Q99437 | |
| VSHPDGQEAKALPPF | 341 | A6NJL1 | |
| SGQNTVEPHKDPDAT | 221 | Q92610 | |
| SHFTQDLPPELGIKD | 91 | Q8IYX0 | |
| LHEAPDNSEGPRDTK | 456 | O94964 | |
| PSFHSPEKLGVFLAQ | 411 | Q658T7 | |
| KGLELSPPHASEASQ | 386 | Q6U7Q0 | |
| TPLNGADKVFPSLDE | 26 | Q5BVD1 | |
| VKVFNAGDDPSVPLH | 116 | O95685 | |
| HVIPGESPFNKSLAS | 851 | Q9P273 | |
| DTLPVKEADGNQPHF | 26 | Q70EL3 | |
| TLHPLDPEENTKSFG | 376 | Q96LQ0 | |
| RPHVSSQDEKDAGPS | 721 | Q6ZSY5 | |
| EDLQKSHSKPPGDEA | 766 | Q70Z35 | |
| SEPPAELALSHDGKV | 1371 | Q9BZZ2 | |
| DPSFLHEALKASNGD | 36 | Q96RU2 | |
| DPSDDTKGFFDPNTH | 3641 | Q15149 | |
| PNTKNHPVRFGSDDE | 86 | P12272 | |
| VHPNPPSVLFGADKD | 761 | Q92797 | |
| FTADSGTPAPEHNEK | 146 | Q9BTX3 | |
| EASAHSHPPEIKDQG | 21 | P11137 | |
| DNLPSAGSQFPDFKH | 151 | Q9NZV7 | |
| KSHSLAQPPEFDSGV | 1576 | Q07157 | |
| DPDKSPFGHNFKETS | 301 | Q8TF39 | |
| PHPLGKEEEKFSDSS | 71 | Q5T619 | |
| LAPNESPKDSPAHEV | 301 | Q7RTT9 | |
| PHLPNSGQEDFDKDG | 721 | P35442 | |
| SNPSLSEEHQPFSGK | 1156 | Q9BXT5 | |
| FASQPSDSPGHKIVL | 566 | P48553 | |
| SHDDSVEGPKEFPQE | 641 | Q13769 | |
| HKPLGFESGEVTPDQ | 66 | O15537 | |
| ALEKTFDNSTVPHPG | 531 | Q9C0B0 | |
| STPHGAKSIIQEFPE | 271 | Q96BW1 | |
| EDSPFQKPLHDSEIA | 1181 | Q92547 | |
| HADGEKEDQFNGSPP | 161 | Q69YN4 | |
| SSEPDHVEVKVGNPF | 1171 | Q68DK2 | |
| KDADPQALGPHVELF | 356 | Q8N228 | |
| HSPFFGDESNKPILL | 1506 | P49815 | |
| KPLDSTEGAAEFHLN | 71 | B6A8C7 | |
| GEAPLQSRSPSEKEH | 811 | P29597 | |
| KVFSLDVPDHPAATG | 641 | Q5R3F8 | |
| VTKFDPDLDLDHPGF | 211 | P07101 | |
| DPRGNDHTDFKNIPI | 411 | Q03721 | |
| PPHFSAGKAKVDTLE | 901 | Q8WXR4 | |
| VHEASPPTFQKDALL | 861 | P52179 |